Send me a link:

*Text messaging rates may apply.

 Dow Up0.17% Nasdaq Up0.44%

Sagent Pharmaceuticals, Inc. (SGNT)

-NMS
26.40 Up 0.16(0.61%) Jul 11, 3:59PM EDT
|After Hours : 26.24 Down 0.16 (0.61%) Jul 11, 4:26PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Net Income 5,119   3,560   2,826   13,370  
Operating Activities, Cash Flows Provided By or Used In
Depreciation1,750  2,908  2,070  822  
Adjustments To Net Income915  758  1,216  (1,255)
Changes In Accounts Receivables(9,913)1,097  (6,155)14,237  
Changes In Liabilities(4,409)6,349  154  (1,806)
Changes In Inventories2,272  2,161  6,136  (2,577)
Changes In Other Operating Activities(129)969  (1,788)(2,400)
Total Cash Flow From Operating Activities (4,395) 17,802   4,459   20,391  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(556)(320)(672)(19)
Investments(534)(4,279)(71,098)3,347  
Other Cash flows from Investing Activities(989)(7,905)(1,546)(8,014)
Total Cash Flows From Investing Activities (2,079) (12,504) (73,316) (4,686)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -   -  
Sale Purchase of Stock149  89  70,804  171  
Net Borrowings(10,324)(8,961) -   -  
Other Cash Flows from Financing Activities -   -   -   -  
Total Cash Flows From Financing Activities (10,175) (8,872) 70,776   171  
Effect Of Exchange Rate Changes55  (31)24   -  
Change In Cash and Cash Equivalents (16,594) (3,605) 1,943   15,876  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.